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Background: T cells play a prominent role in the etiopathogenesis of 
periodontal disease. The Th1/Th2 paradigm which has been used to 
explain the pathogenic mechanisms involved in periodontal disease, was 
based on the cytokine profile. Establishment of Th1 and Th2 subsets 
largely depends on its transcriptional regulation. Hence the aim of the 
study is to evaluate the transcriptional regulation of Th1 and Th2 subsets 
(T- bet and GATA-3), in Periodontal Health and Disease. 
Materials and methods: Ten gingival tissue biopsy samples from each 
group of patients (periodontal health-Group A and periodontal disease- 
Group B) were obtained. The samples were processed for real time reverse 
transcription polymerase chain reaction to detect the mRNA expression of T-
bet and GATA-3 in periodontal health and disease samples.  
Results: The mRNA expression of the master transcription factor of Th1 
subset, T- bet showed a marginal increase of about 1.31 fold, which was 
insignificant, while the GATA-3 levels showed a 4.39 fold decrease from 
disease to health. 
Conclusion: The results of this study indicates that the advanced 
periodontal lesions are more likely to be dominated by Th1, rather than 
Th2.  






Periodontitis is an inflammatory disease of the supporting tissues of the 
teeth caused by specific micro organisms or groups of specific micro 
organisms resulting in progressive destruction of the periodontal ligament 
and alveolar bone with pocket formation, recession or both.
105
It is now 
recognised that although periodontitis is microbial in origin, destructive 
processes are mediated through an exaggerated host response resulting in 
increased proinflammatory cytokine release. The imbalance between the 




The central role played by T cells in the etiopathogenesis of periodontal 
disease was recognized following the seminal work of Ivanher and 
Leanyi.
62
 However, with a greater understanding of their biological 
functions, T cells are now believed to be involved in the homeostasis of 
periodontal tissues,
41
 modulation of the inflammatory/immune responses
12
 
and mediation of the bone loss observed in periodontal disease.
150
 
In periodontal disease, cytokines are central to the pathogenic process 
involved in disease activity. It has been postulated that "appropriate" 
cytokine production results in protective immunity, while "inappropriate" 






                T cells are classified based on their function into various 
categories such as helper T (Th) Cells, cytotoxic T (Tc) cells and regulatory 
T (Treg) cells. 
 
Originally, the presence of two different subsets of Th cells-Th1 and Th2 
was described by Parish and Liew. Later, Mossman and Coffman 
106 
delineated two distinct cytokine profiles associated with the Th1 and Th2 
cells. 
 
Macrophage activity leading to osteoclastogenesis has been reported to be 
associated with the bone destruction observed in periodontal disease.
146,149 
Th1 cells are believed to have evolved to afford protection against the 
intracellular pathogens. These cells produce the interferons (IFN) that are 
involved in macrophage activation, which in turn plays an important role in 
phagocytosis, complement fixation and opsonization.
114
 Th2 cells are 
thought to have evolved as protection against parasitic helminths. These 
cells produce IL-4 in addition to IL-5 and IL-13; cytokines that are involved 
in immunoglobulin (Ig) class switching in B cells. The importance of IgG 
that is produced as a result of this class switching in periodontal disease 






Naive T-Helper cells can be differentiated into either TH-1 cells or TH-2 




 stated that the Th1 cell expresses the IL-12 receptor 
subunit IL-12R2, which further commits a cell to proceed along this 
differentiation program. This process is dependent on the transcription 
factor STAT-4, which is activated by IL-12, and also on T-bet, which is 
considered the master regulator of the Th1 lineage.
49 
Conversely, when a newly activated Th cell is exposed to IL-4, 
differentiation to a Th2 phenotype occurs. Th2 cells secrete IL-4, IL-5, and 
IL-13, which are co-regulated transcriptionally. 
Yamazaki.K et al, in 2007,
 
stated that Th2 development is dependent on the 
transcription factors STAT-6, GATA-3, and c - maf. Th1 and Th2 
development is mutually antagonistic and self-reinforcing, in part because 
IL-4 and IFN- antagonize one another at cellular and molecular levels.162 
Although a number of studies have documented the preponderance of either 
the Th1/Th2 signature cytokines in tissues, saliva, GCF, however there are 
fewer reports on the transcriptional activity within the gingival tissues. 
 




Aims & Objectives: 
 The aim of this study is to evaluate the mRNA expression of the 
transcription factors of Th1 and Th2 subsets namely T-bet and GATA-3 








REVIEW OF LITERATURE 
Periodontitis is defined as an inflammatory disease of the supporting tissues 
of the teeth caused by specific micro organisms or groups of specific micro 
organisms resulting in progressive destruction of the periodontal ligament 




Chronic inflammatory periodontal disease results from the inflammatory 
response to bacteria in dental plaque and may either remain confined to 
gingival tissues or progress leading to attachment loss. Disease progression 
is due to combination of factors including the presence of periodontopathic 
bacteria and high level of pro-inflammatory cytokines, MMPS, PGE2 and 
low levels of anti-inflammatory cytokines (IL-10, TGF-, and TIMMPS).  
 
The adaptive immune response is under the control of T cells which 
regulate B cell/ plasma cell differentiation and antibody production. 
Clearance of bacteria by neutrophils may depend upon the presence of IFN-
 and further enhanced by protective antibodies which in turn control by the 
types of cytokines produced by T cells.( Page R.C , Offenbacher S , 
Schroeder H.E, Seymour  G.J )
105 
 




Cytokines are characterized by their pleiotropism and pluripotentiality. 
Certain cytokines-including interleukin-1 (IL-1), IL-6, IL-8, IL-12, tumor 
necrosis factor alpha (TNF-α), and interferon gamma (IFN-)-serve 
predominantly pro-inflammatory functions (Dinarello, 1987).
28
 These 
cytokines are produced by or act on mononuclear phagocytes and other cell 
types to upregulate adhesion molecules, immunoglobulin Fc receptors, 
nitric oxide synthesis, eicosanoid and metalloprotease production, and 
cytokine secretion. They also promote connective tissue and endothelial cell 
activation. Other cytokines generally function in an anti-inflammatory role. 
These include IL-1 receptor antagonist (IL-lra), IL-13, and transforming 




 documented that T cells are involved in nearly all 
immunoregulatory interactions both in vivo and in vitro. Prothymocytes 
migrate to the thymus gland where they are processed, become functionally 
competent, and then exported into the peripheral lymphoid compartment. 
There are distinct subpopulations of peripheral T cells and the delicate 
balance between effector and regulatory subsets that normally exists is 
required for immune homeostasis.
 
  
Over two decades ago, Mosmann and Coffman 1986,
92
 proposed a model 
wherein T helper (Th) cells are divided into functional subsets on the basis 
of cytokine secretion, termed Th1 and Th2. Th1 cells secrete IFN, and 




thereby activate macrophages, NK cells, and CD8+ T-cells (collectively 
termed “cell-mediated immunity”, or CMI). Th1 cytokines also influence B-
cells to secrete opsonizing antibody isotypes that further enhance antigen 
uptake and presentation to T-cells. Until recently, Th1 cells were also 
thought to be the major effectors of immunity to extracellular pathogens and 
autoimmunity. Th2 cells, in contrast, mediate humoral immunity, including 
production of IgE and activate mast cells, which drive immune responses to 
helminths. 
 
Numerous studies have attempted to delineate the Th1-Th2 cytokine profile in 
chronic periodontitis in humans. Page and Schroeder, et al 1976,
105
 stated 
that during the early stage, the inflammatory infiltrate is mostly T-cells, 
whereas in the established lesions, B-cells become the most common 
inflammatory cells. 
 
While some controversy still exists regarding these profiles, the fact is that, 
the stable periodontal lesion is identical to a delayed type hypersensitivity 
reaction. This suggests that stable lesions are mediated by Th1 cells and 
progressive lesions involving B cells and plasma cells are mediated by Th2 
cells. In chronic periodontitis the T cell receptor (TCR) seems to direct the 
Th1 response while low affinity TCR involvement tends towards Th2 
response. This TCR affinity in chronic periodontitis has not been 




investigated so the mechanism which controls Th1, Th2 profiles includes 
the nature of antigen presentation and innate immune response.  
 
Innate versus adaptive immunity:- 
Since birth, our immune system is constantly encountered with self-antigens, 
innocuous antigens and foreign pathogens, such as airborne and food-borne 
viruses, bacteria and parasites. To stay healthy, complex immune strategies 
have evolved in mammals to maintain self-tolerance and to defend against 
foreign pathogens. To accomplish such a task, the immune system has 
developed mechanisms to efficiently cope with these insults in the living 
species.  
The two fundamental arms of the immune response, innate and adaptive 
immunity, together form a defensive front against pathogens. Innate immunity 
evolved earlier and is mediated by cells such as macrophages and dendritic 
cells (DC) and is specific only to a few classes of microorganisms. The later 
evolved adaptive immunity mediated by T and B cells and enhances pathogen 
eradication in vertebrates by adding antigen specificity and memory onto pre-
existent innate immunity. 
 
 




Immunity- the state of protection from infectious disease has both 
nonspecific and specific components. The nonspecific component, innate 
immunity, provides the first line of defence during the critical period just 
after the host’s exposure to a pathogen. Phagocytic cells such as 
macrophages play an important role in many aspects of innate immunity. In 
contrast, the specific component, adaptive immunity, displays a high degree 
of specificity as well as the remarkable property of “Memory”. 
Exposure to the same antigen sometime later in future results in a memory 
response of the immune system to the second exposure more quickly than 
the first. This response is stronger and often more effective in neutralising 
and clearing the pathogen. If an invading microorganism eludes innate 
mechanisms or is not cleared by them, the specific immune response of 
adaptive immunity is triggered. Adaptive and innate immunity do not 
operate independently of each other, they function as a highly interactive 
and cooperative system, producing a total response more effective than 










Concepts in periodontal disease pathogenesis: 
 
 
Salvi and Lang, 2005,
117
 documented that in a linear model (A), the 
bacteria are seen as initiators of the inflammatory process. Disease 
progression depends exclusively on the host response, which offers a target 
(*) for therapeutic intervention (e.g., anti-inflammatory agents) . 
The circular model (B) contends that bacteria are necessary for both 
initiation and progression of the disease, by constantly shaping the T-cell 




response through differential TLR-mediated activation of APC and secreted 
cytokines. 
The innate and adaptive host response, in turn, determines the fate of the 
infection, and consequently whether inflammation will progress to disease 
or be controlled. Although the role of the individual effector Th subsets is 
debatable, Gemmell et al., 2002, 
47
 stated that Th2 cells have been 
associated with non protective antibody responses and progressive 
periodontal lesions, and Th1 with stable lesions.  
Th1 cells are thought to protect through IL-12/IFN stimulated cell-
mediated immunity (Alayan et al., 2007;) 
4 
and by inhibition of 
osteoclastogenesis (Gowen et al., 1986; Horwood et al., 2001).
51,52
 In 
contrast, Sato et al., 2006,
121
 documented that Th17 cells have been 
implicated as a specialized osteoclastogenic subset that links T-cell 
activation to bone loss. Periodontal bone loss and soft-tissue alterations 
offer new niches for colonization (generation of deep periodontal pockets) 
and thus facilitate bacterial overgrowth; this model offers three types of 
targets for therapeutic intervention: antimicrobial (*1), TLR-based 








 PERIODONTAL DISEASE AND CELL-MEDIATED 
IMMUNITY: 
Periodontitis is an infection-driven chronic inflammatory disease affecting 
the integrity of tooth-supporting tissues. Subgingival bacterial pathogens are 
essential for the initiation and progression of the disease, although it is the 
resulting host reaction that primarily mediates tissue damage (Baker, 2000; 
Taubman et al., 2005).
13,146 
 
Gemmell et al.,2007; Kinane et al., 2007,
41,44 
had reviewed that the 
periodontal host response is highly complex; it contains both protective and 
destructive elements, and may be proactively modified by immune-
subverting pathogens. Despite almost four decades of intensive research, the 
precise role of the host response in periodontitis and how it can be 
harnessed therapeutically are far from resolved.  
In one of the first reports by Ivanyi and Lehner, 1970 
62 
addressing a role 
for CMI in periodontitis, the authors concluded that “the cell mediated 
immune response to some oral micro-organisms may play a protective or 
aggressive part in the pathogenesis of periodontal disease”. In a case with 
inflammatory diseases, CMI would be expected to play a pathological role 
in periodontitis.  
However, the experimental studies conducted by Ivanyi and Lehner, 1970 
62
 have shown the protective function of CMI because they observed 




suppressed CMI in individuals with advanced periodontitis compared with 
those with mild disease. This statement is still relevant, despite a flurry of 
discoveries and advancements in their understanding of T-cell subsets and 
their cytokines, as well as the innate immune mechanisms involved in their 
regulation.  
 
Early immunohistological studies by Page and Schroeder, 1976; reviewed 
by Gemmell et al., 2007
105
 in humans established that the early periodontal 
lesion (gingivitis) is characterized by increased numbers of T-cells and 
macrophages, whereas the progressive lesion (leading to periodontitis) is 
associated with increased infiltration by B-cells and plasma cells.  
Evans et al., 1989
31
 had stated that after periodontal treatment there is 
suppressed potential for the induction of CMI in advanced periodontitis. 
It was thus proposed that periodontal bacteria play an active role in 
suppressing CMI, thereby inducing the transition from an early/stable lesion 












 T-CELL-MEDIATED IMMUNITY IN THE PERIODONTIUM: 
It is generally accepted that systemic immune status can affect local 
immune responses, including the periodontium, and that periodontal disease 
progression is critically determined by the nature of inflammatory responses 
generated in response to the challenges from the subgingival micro-
organisms (or biofilm).  
The study of various genetic knockout and immunodeficient mouse strains 
and the use of advanced cellular and molecular biology techniques have 
brought the new understanding and insights into the nature of, and 
regulations associated with, inflammatory events in the periodontium. 
Baker et al., 1994, 1999, 2002,
13,14
 In addition to the protective and 
somewhat unclear inflammatory and anti-inflammatory activity of humoral 
Ig immunity in the periodontium, it is now clear that when the host's T-cell-
mediated immune system is absent or deficient during the course of 
periodontal infection, compared with that of the immunocompetent host, 
there is much less tissue inflammation and alveolar bone destruction.  
 
Seymour and Gemmell, 2001; Gemmell et al., 2002,
127
 documented that 
CD8+ T-cells may be involved in killing and removing some bacteria-
infected or damaged host cells, they do not directly mediate the periodontal 
destruction in situ. Importantly, CD4+ T-cells and other Phagocytic lineage 
or innate immune cells are critically involved in effective defenses to 
eradicate the invading pathogens and directly participate in tissue 




inflammatory responses and alveolar bone destruction, in particular, through 
the cytokines they produce. 
 
Seymour and Gemmell, 2001; Taubman and Kawai, 2001,
126
 stated that 
cytokines expressed locally in the periodontal tissues and by the 
inflammatory cells contribute to the state of protective vs. destructive 
phases of the disease progression. 
 
Baker et al., 1999; Garlet et al., 2003 
13,39  
in their experimental studies had 
clearly shown that, based on cytokine expression profiles, (i) both Th1 and 
Th2 cells and cytokines are often present simultaneously in the infected 
periodontal tissues , and (ii) pathogen-reactive Th1 cells and the cytokines 
they produce (i.e.,IFN-) can mediate the active inflammatory response 
associated with tissue and alveolar bone destruction (Kawai et al.,2000; 
Taubman and Kawai, 2001).
72 
 
Cytokines are of major importance in periodontal disease progression. It is 
generally agreed that control of the Th1/Th2 balance is central to the 
immunoregulation of periodontal disease. There is increasing evidence in 
humans that the stable periodontal lesion is mediated by Th1 cells, while the 
progressive lesion sees a shift toward Th2 cells. Equally, there is conflicting 
evidence, mainly in animal models, that bone loss is mediated by Th1 
responses, and that Th2 responses are protective. In the presence of IL-12, 




IL-18 induces Th1 responses while, in the absence of IL-12, it promotes 
Th2 responses. It is clear, therefore, that since IL-18 has the ability to 
induce either Th1 or Th2 differentiation, and it becomes important to 
consider its role in periodontal disease. 
 
Key Cytokines in Periodontal Disease:  
 
Although individual PRR (pattern recognition receptor) ligands in various 
periodontal pathogens have the potential to modulate the T-cell response, 
the pathogenesis of periodontitis might be too complex by distinct T-cell 
subsets. Since this disease is polymicrobial, pathogens may modulate the T-
cell response to promote their own adaptive strength, and the net immune 
response is mediated by all the microbes represented in the biofilm.              
Therefore, it may not be possible to dissect dominant Th1, Th2, activity 
patterns reliably among collected samples of diseased periodontal tissue. 
Accordingly, it might be simpler and more productive to consider the roles 
of individual Th1, Th2, cytokines in periodontal infection.  
 
  IL-12: 
Trinchieri et al., 2003
153
 documented that IL-12p70 plays a key role in 
mediating bacterial clearance through the induction of IFN-, which in turn 
activates the bactericidal function of macrophages. Karp et al., 1996,
71
 had 
shown that several pathogens have developed mechanisms for IL-12 




suppression. Several animal studies have examined the role of IL-12 in 
protection against periodontal pathogens.  
 
Alayan et al., 2007,
4
 had shown that IL-12p40 deficient mice exhibit a 
reduced inflammatory cell infiltrate, but increased tissue destruction, upon 
subcutaneous challenge with P. gingivalis. In contrast, mice deficient in 
Th2 cytokines, such as IL-4 or IL-10, did not display increased 
susceptibility to P. gingivalis-induced tissue destruction. Moreover, IL-
12p40 deficient mice are more susceptible to naturally occurring murine 
periodontitis than are wild-type controls. These findings could be 
interpreted to mean that IL-12 is important for the immune and 
inflammatory responses that control P. gingivalis infection. 
 
In another study, Johnson and Serio, 2005,
66
 shown that IFN- and IL-12 
were negatively correlated with gingival sulcular depth, in contrast to other 
cytokines (IL-6 and IL-18) that displayed positive correlations and were 
thus thought to contribute to non-resolving inflammation. 
 
Hajishengallis etal., 2007; Wang et al., 2007,
54
 was hypothesized in these 
studies that periodontal infection and resulting inflammation may persist 
due to decreased IL-12 levels. In addition, P. gingivalis possesses a 
mechanism for inhibiting the production of IL-12 and IFN- in humans and 
mice and for degrading human IL-12 (Yun et al., 2001). 
168 





Gemmell et al., 2006,
43
 documented P. gingivalis has the potential to 
induce a immunosuppression of CD4+ and CD8+ T-cells in mice. 
 
IL-10: 
Sasaki et al., 2004,
119
 had reported that IL-10 deficient mice display 
increased susceptibility to P. gingivalis-induced periodontal bone loss, 
further supporting a role for IL-10 in the control of destructive 
inflammation.  Sasaki et al., 2008,
120
 had reported that mice with an 
additional deficiency of IL-12p40, i.e., IL-10 deficient and IL-12p40 
deficient mice, are rendered resistant to periodontal bone loss in the same 
experimental model, and so are T-cell/IL-10 double-deficient mice. 
However, since IL-12p40 is shared between IL-12p70 and IL-23, it is 
uncertain whether Th1 or Th17 cells mediate periodontal destructive effects 
in this hyper inflammatory model of IL-10 deficiency.  
In fact, a role for Th1 cells in inflammatory bone resorption has been ruled 
out, in rheumatoid arthritis, where they actually inhibit osteoclastogenesis 
(Sato et al., 2006).
121
 There is a balance of pro and anti-inflammatory 
cytokines, and may be more important for protection against infection-
induced destructive inflammation than a strong polarized response on either 
side.  




This concept is supported by Alayan et al., 2007,
5
 in another study they 
found that deficiencies in either Th1 (IL-12, IFN-) or Th2 cytokines (IL-4) 
resulted in periodontitis. 
The periodontal health represents a state where, the activity of pro-
inflammatory/antimicrobial cytokines which controls infection is balanced 
by anti-inflammatory mechanisms to prevent unwanted inflammation. In 
contrast, when this balance is disrupted, either due to pathogens that 
dysregulate host defense mechanisms or genetic differences in host 
immunity, disease progression and tissue destruction may occur.  
 
In a recent review by Gemmell et al., 2007,
41 
 it was hypothesized that the 
role of T-cells in periodontal disease may not be one of protection or 
destruction, but rather that T-cells play a homeostatic role in maintaining a 




have hypothesized that would include the 
participation of CD4+CD25+ regulatory T-cells (Tregs), which suppress 
Th1 and Th2 responses, although their effects on Th17 cells are largely 
unknown .In contrast to a balanced state, Stashenko et al., 2007
134
 had 
reported, strongly polarized response in any direction may be detrimental to 
the host.  
 




Kawai et al., 2000,
72
 in his experimental studies have shown that gingival 
injection of rats with A. actinomycetemcomitans 29-kDa outer membrane 
protein and LPS, followed by adoptive transfer of antigen-specific Th1 
clone cells, leads to high levels of bone resorption. Whereas these studies 
underscore the potential for destructive inflammation in strongly biased Th1 
conditions, they do not necessarily rule out Th1-mediated protection under 
more balanced, physiological conditions. 
 
Interleukin 1 (IL-1): 
Dinarello, 1987,
28 
have reported that IL-1 is a principal mediator of 
inflammatory responses acting on many cell types other than those of the 
immune system and is itself produced by many different cells, including 
macrophages, endothelial cells, B cells, fibroblasts, epithelial cells, and 
osteoblasts in response to microorganisms, bacterial endotoxin or exotoxins, 
complement components, or tissue injury.   
 
Dinarello, 1987 et al,
28
 in his studies isolated the cDNA clones, that have 
shown two forms, IL-1 alpha and IL- 1 beta, both of which bind to the same 
receptor and have identical biological properties. IL-1 has a central role in T 
cell activation resulting in transcription of various genes, including IL-2 and 
CD25 (IL-2 receptors), and the activated T cell then secretes a number of 
cytokines that affect the cells in the immune response (Janeway, 1989).
63
 




IL-1 appears to potentiate proliferation and/or differentiation of mitogen or 
antigen activated B cells rather than have a direct effect, as it does on T 
cells so that IL-1 may act by priming B cells to respond to subsequent 
activation (Freedman et al., 1988).
34 
 
Dewhirst et al., 1985,
27
 have reported that IL-1 plays an important role in 
bone resorption, which is a feature of chronic inflammatory diseases such as 
periodontal disease and rheumatoid arthritis.  
 
Matsushima et al., 1985,
86
 have stated that B cells, which are present in 
increased numbers in the progressive periodontal lesion, have been shown 
to produce IL-1 and therefore may be an important factor in the bone loss 
that occurs in this disease. 
 
Interleukin 2 (IL-2): 
IL-2 was first discovered through its activity as a T cell growth factor. It is 
secreted and synthesized by T cells after activation by antigen or mitogen 
and plays an essential role in T cell division.  O'Garra, 1989,
99
 reviewed 
that IL-2 act also as an autocrine growth factor, it also induces T cell 
cytotoxicity and natural killer (NK) cell activity.  




Miyawaki et al., 1987,
89
 had reported that IL-2 also acts as a growth factor 
for activated human and murine B-blast cells by inducing increased Ig 
secretion. 
 
Interferon Gamma (IFN-Gamma): 
Morris et al., 1988; O'Garra, 1989,
91,99
 have reported that IFN-gamma is 
produced during an immune response by antigen-specific T cells and NK 
cells recruited by IL-2. Its regulatory effects include the activation of 
macrophages to enhance their phagocytosis and tumor-killing capability as 
well as activation and growth enhancement of CTL and NK cells.  
 
Snapper and Paul, 1987; Finkelman et al., 1988,
133,32
 have stated that 
IFN-gamma plays a major role in the control of immunoglobulin isotypes 
produced during an immune response. In the mouse IgG2a is enhanced with 
suppression of other IgG isotypes and IgE. Finkelman et al., 1988,
32
 have 
stated that IgG2a is very effective at fixing complement and promoting NK 
cell-mediated killing so that IFN-gamma promotes the ability of the 




 reviewed that IFN-gamma inhibits most of the activities 
induced by IL-4, suggesting that these two cytokines reciprocally regulate 
Ig isotype production in T-cell dependent immune responses. Scott, 1993 






 the presence of IFN-gamma appears to be a requisite for the 
induction of the Thl subset. 
 
Interleukin 4 (IL-4): 
Sher et al., 1992,
128
 reviewed that, IL-4 produced by T cells, mast cells, and 
basophils and is an important factor in the clonal expansion of antigen- 
specific B cells. This IL-4 enhances the synthesis of IgE in both the mouse 
(Coffman et al., 1986)
20
 and human (Del Prete et al., 1988),
26
 IgGl in 
murine B cells (Coffman et al., 1986),
20
 and IgG4 in human cells 
(Lundgren et al., 1989).
84 
Therefore, it would appear that IL-4 modulates 
humoral responses to different antigenic stimuli. IL-4 contributes to 
negative immune regulation by its ability to reduce IL-2 receptors and thus 
inhibiting some IL-2-induced activities. These include the IL-2-induced 
generation of NK cells and IFN-gamma-enhanced activities, including the 




IL-4 can also block macrophage nitric oxide generation necessary for the 
killing of intracellular parasites (reviewed in Modlin and Nutman, 1993).
90
 
In the current review, it is interesting to note that treatment of mice with 
either IL-4 or anti-1L-4 antibodies has demonstrated that the differentiation 
of Th0 clones toward a Th2 phenotype is dependent on the presence of IL-4 
(Scott, 1993)
124 






Interleukin 5 (IL-5) : 
IL-5 has several effects on B cells, including the induction of IgM and IgA 
production. O'Garra, 1989,
99
 had stated that this cytokine is chemotactic 
for and is a potent stimulus for the growth and differentiation of 
eosinophils. 
 
Interleukin 6 (IL-6): 
O'Garra, 1989,
99 
reviewed that IL-6 is produced by both hemopoietic and 
nonhemopoietic cells and induces immunoglobulin secretion in both 
preactivated murine and human B cells and therefore induces the final 
maturation of B cells into high rate Ig-secreting cells. IL-6 activity is not 




restricted to B cells and appears to be a key member of the cytokine 
network being expressed at high levels by many cell types both 
constitutively or after activation and interacts with many targets (Tovey et 
al., 1988).
152
 Like IL-1, it appears to have a major role in the mediation of 
inflammatory and immune responses initiated by infection or injury. IL-6 
activates T and B cells, stimulates hemopoietic, and both IL- I and IL-6 
seem to mediate most of the effects ascribed to macrophages in lymphocyte 
activation (Van Snick and Nordon, 1990)
158 
 
Th1/Th2 cells in periodontal disease: 
Several studies have discussed the role of Th1 and Th2 cells and their 
cytokine profiles in periodontal disease. Over the past decade, it has been 
proposed that as stable periodontal lesions resemble a delayed type 
hypersensitivity lesion and progressive lesion involves large number of B 
cells, these lesions may be mediated by Th1 and Th2 cells respectively.  
It has been shown that a strong innate response leads to a Th1 response 
under the influence of IL-12, IL-2, IFN-γ, while a weak innate response 
leads to a Th2 response under the influence of IL-4 cytokines. In a stable 
lesion, IFN-γ enhances the Phagocytic activity of both neutrophils and 
macrophages and hence contains the infection.  In case of a poor innate 
immune response and minimal Il-12 production, a weak Th1 response may 
not contain infection.  




Mast cell stimulation and the subsequent production of IL-4 would 
encourage a Th2 response, B cell activation and antibody production. If 
these antibodies are protective and clear infection, the disease will not 
progress but if they are not protective, as in case of IgG2, the lesion will 
persist. Continued B-cell activation may result in large amounts of IL-1 and 
hence tissue destruction. 
Despite its simplicity, the Th1/Th2 model does not adequately explain many 
findings with respect to T-cell mediated immune responses. Various studies 
have reported discrepancies with regard to predominance of Th1 or Th2 
response or the involvement of both Th1 and Th2 cells in diseased tissue.  
 
Antigen recognition, Processing and Presentation: 
About 95% of T cells in peripheral blood express a TCR comprising a αβ 
chain; the remaining T cells express a γδ TCR. CD4 and CD8 molecules act 
as co receptors with TCR. Each T cell has a unique receptor generated by 
recombination of a variable (V), diversity (D), and joining (J) gene 
segments during thymic maturation. This random process generates many 
non functional receptors, which die by a process called positive selection. 
Self reactive T cells are eliminated by a process called negative selection, 




which is one of the mechanisms by which immune system is made tolerant 
and does not attack self cells.  
 
Yamazaki K, Nakajima T etal 2004,
163
 has stated that T cells do not 
recognise whole antigen. Proteins derived from infectious organisms are 
taken up by antigen presenting cells processed into antigen peptides and 
presented on cell surface by binding to a peptide binding groove of MHC.  
 




Antigen processing is divided into 2 pathways which lead to peptide 
fragments being presented by MHC class I or Class II molecules. Proteins 
that are derived within the cells such as those produced during viral or 
intracellular bacterial infections are processed by endogenous pathway. 
Proteins derived from outside the cell such as antigens phagocytosed by 
macrophages and dendritic cells are processed by exogenous pathway. 
King CA, Wills MR et al 2005,
76
 has stated that all cells in body are 
capable of processing and presenting antigens via MHC class I pathway. 
Only professional Antigen presenting cells bear MHC class II and present 
antigens to CD4+ T cells.  
Yamazaki K, Nakajima T.et al
163
 have stated that non peptide antigen is 
recognised by CD1 expression on antigen presenting cells- monocytes, B 
cells and dendritic cells.
 
Group 1 CD1 (a, b, c) are expressed by 
professional APCs.  
Amanuma R, Nakajima T et al 2006 
6 
have stated that CD1d is expressed 
by monocytes, macrophages, B cells.CD1d presents self lipids to specific T 








 T cell Subsets: 
T cells are functionally divided into T helper, regulatory and cytotoxic cells. 
Helper and suppressor cells help to regulate immune response by releasing a 
variety of regulatory mediators or cytokines. Cytotoxic cells are able to kill 
other cells through cell-cell interactions. Cells of the innate response 
influence T cell differentiation by influencing the cytokine milieu in tissues 
or by draining lymph nodes where antigen specific T cells expand in 
response to antigen presentation.  
Ansel KM, Lee DU, Rao.A et al 
8
 upon antigenic stimulation, naïve CD4 + T 
cells can be differentiated into diverse T helper cell subsets like Th1, Th2, 
Th17 and Treg. From in vitro and in vivo studies, instructive cytokines and 
transcription factors which are specific for each effector lineage were 
identified. In the early initiation stage, the unique signal transducer and 
activator of transcription (STAT) are activated by the environmental cytokine 
signal which leads to induction of lineage master regulators. Transcription 
factors from each distinct subset activate and control the various downstream 
genes and this mechanism is further enhanced and stabilizes the lineage 
commitment with epigenetic modification by specific stimuli and the action of 
transcription factors. As a result, effector cytokines and modulators can be 
released from each CD4 + T helper cell subsets and these further regulate 
immune responses accordingly to antigens. 






Powrie and Coffman, 1993,
108 
have stated that a successful immune 
response to an infectious agent is dependent on activation of appropriate 




documented that extracellular pathogens are generally 
eliminated by antibody binding that facilitates complement fixation, 
phagocytosis, and activation of the Fc-dependent release of reactive 
oxygen species by monocytes/macrophages and polymorphonuclear 
neutrophils (PMN) . 
Elimination of intracellular pathogens (viruses and certain bacteria) depends 
on the destruction of the infected cell by antigen-specific cytolytic T cells 
(CTL) and activated macrophages (Kelso, 1990).
74 
 Inactivation of other organisms occurs by the release of enzyme-rich 
granules from     eosinophils and mast cells as in the case of helminths, 








Bloom et al., 1992,
18
 had shown the evidence that human CD4+ T cells 




 has stated that Thl cytokines are generally elevated in 
successful responses to many intracellular pathogens, while Th2 cytokines 
are elevated in allergic diseases and helminths infections. Th2 cells 
stimulate mast cells, eosinophils and IgE antibodies. Th1 cells increase the 
ability of macrophages to kill intracellular and extracellular pathogens and 
also mediate delayed type hypersensitivity (DTH) reactions. Th1 and Th2 
cells play different roles not only in protection against exogenous antigens 
but also in immunopathology. Therefore, each T helper subset induces and 
regulates effector functions targeted at different antigens and pathogens.  
Although most studies have been on CD4+ cells, it has been reported that 
the majority of CD8+ T cells also have a Thl-like profile.  
 
Street and Mosmann, 1991,
93
 have been reviewed that these T cells are 
cytotoxic and although the pattern of secretion is Thl, IL-2 secretion is low 
or undetectable. Bloom et al.1992,
18
 have stated that IFN-gamma is 
secreted at about the same level as Th1 clones, whereas most other 




cytokines are secreted at lower levels. There is evidence that Th2-like CD8+ 
T cells also occur in both the human and mouse.  
Recently, a report by Inoue et al., 1993,
59 
shown that cytolytic CD8+ T 
cells could not suppress CD4+ T cells, whereas suppressor CD8+ T cells 
could suppress the proliferative responses of both Th1 and Th2 CD4+ cells 
by the production of IL-10. It is now evident that the pattern of cytokine 
production by both CD4+ and CD8+ T cells appears to be related to the 
function of the cell rather than to phenotype and Bloom et al.(1992)
18 
have 
proposed the general concept of type 1 and type 2 T cell subsets (Figure ) 
 
Scott and Kaufmann, 1991,
122 
had reported that the division of CD4+ T 
cells into distinct subsets based on cytokine production could represent a 
major advance in understanding immune responses, particularly those 




associated with infectious disease. Mosmann, 1991,
93
 have reviewed that 
most resting T cells secrete IL-2 when first stimulated and then differentiate 




 have stated that Th1 cells produce IL-2 and IFN-
gamma, whereas Th2 cells secrete IL-4, IL-5, and IL-6 after activation by 
antigen or mitogen. de Waal malefyt et al., 1992,
25
 have stated that both 
types of T cells produce IL-10 &1L-13. 
 
de Waal Malefyt et al., 1992,
25
 had reported a third category of Th cell 
clones can produce all of these cytokines and have been designated Th0 
cells. It has been established that murine IL-2 and IL-4 producing clones 
can be derived from the same cells, suggesting that cytokine phenotype is 
acquired during T cell differentiation and is not secondary to the expansion 





believed that on activation, antigen-specific 
naive CD45+ T cells progress into a Th0 cell and then differentiate further 
into Thl or Th2 cells with repeated antigen stimulation. Mosmann, 1991,
93
 
have stated that this differentiation of cells secreting distinct cytokine 
patterns is assumed to be under the influence of signals from APC and 









 have stated that several secretion patterns seen in short 
term in vitro clones may represent early stages in the differentiation 
pathway and the Thl and Th2 cytokine profiles are assumed to represent 
final chronically stimulated helper T cells. Strong antiparasitic responses are 




 have shown that the use of cytokines and anti-cytokine 
antibodies in animal experiments has confirmed that once a Th1 or Th2 type 
of response is determined early during an immune response, it remains 
stable unless major changes take place in the balance of cytokine production 
during the response. 
 
Street and Mosmann, 1991,
93
 had stated the functions of Th1 and Th2 
CD4+ T cell subsets correlate with the cytokines they secrete. One of the 
major functions of helper T cells is to provide help for B cells to proliferate 
and differentiate into antibody secreting cells following exposure to antigen. 
This ability depends on the concentration of cytokines at the time of T-B 
cell interaction. Low levels of IFN-gamma produced by Thl cells induces 
antibody with an IgG2a isotypes, but high levels of this cytokine will have 




an inhibitory effect on B cell responses. The result of Thl interaction can 
therefore be help or suppression of antibody production. 
 
Street and Mosmann, 1991, reviewed that Th2 clones provide help for the 
formation of IgM, IgGI (mouse) or IgG4 (human), IgA, and IgE because of 
the production of the B cell proliferation and differentiation factors, IL-4, 
IL-5, and IL-6. Coffman and Carty, 1986,
20
 have stated that IFN-gamma, 
on the other hand, inhibits the IL-4-induced IgE response.  
Street and Mosmann, 1991, in vivo studies using cytokines and anti-
cytokine antibodies have supported these observations providing support for 
the concept that the functional abilities of the Thl and Th2 subsets are 
mainly due to the cytokines they produce. 
Recent studies by Cox and Liew, 1992,
22
 suggest that the immune response 
to infection is in fact regulated by the balance between Th 1 and Th2 
cytokines. These two pathways are often mutually exclusive, the one 
resulting in protection and the other in progression of the disease.  
 
Recent studies by Modlin and Nutman, 1993,
90
 have been focused on the 
cytokines that are responsible for immunity on the one hand or pathology on 
the other. The net effect of the Thl cytokines IL-2 and INF-gamma is to 
enhance cell-mediated responses, while that of the Th2 cytokine IL-4 is to 
suppress cell-mediated responses and hence enhance the resistance 
associated with immunity. 




T cell activation: 
First signal is specific requiring TCR recognising and binding to antigen 
bound MHC presented by antigen presenting cells. Second signal is non-
specific (co-stimulatory molecules), If T cells receive these 2 signals, they 
will undergo proliferation, differentiation and then acquire effector function 
 
Fig : Antigen presentation and T cell activation 
Co stimulatory molecules belong to Ig super family, TNFR family and 
integrin family. CD28 co stimulation in T cells augments production of IL-
2, promote cell cycle progression, induce effector cytokine production, 
suppress cell death by altering bcl-2, caspase protein function and enhance 
memory cell development. 





                        Fig : co-stimulators for T- Cell activation 
Antigen presenting cells express co stimulatory molecules such as CD80, 
CD86, and CD40 which will engage T cells and amplify TCR signalling 
through their corresponding receptors CD28, CD40L. Binding of CTLA4 to 
B7 molecules plays an essential role in limiting the actively proliferating 
responses of activated T cells to antigens and B7 on surface of APCs. 
 
Th1/Th2 PARADIGM: 
O’Garra and Vieira, 2007,97 had reviewed that when a naïve CD4+ T-cell 
is exposed to antigen, IL-12 derived from macrophages or dendritic cells, 
drives it to develop into a Th1 phenotype, characterized by the secretion of 
IFN. Other cytokines, such as IL-2, lymphotoxin (TNF), and IL-10, have 
also been called Th1 cytokines, but none defines this lineage as clearly.  
 






 have stated that The Th1 cell expresses the IL-12 
receptor subunit IL-12R2, which further commits a cell to proceed along 
this differentiation program. This process is dependent on the transcription 
factor STAT-4, which is activated by IL-12, and also on T-bet, which is 
considered the master regulator of the Th1 lineage. 
Conversely, when a newly activated Th cell is exposed to IL-4, 
differentiation to a Th2 phenotype occurs. Th2 cells secrete IL-4, IL-5, and 
IL-13, which are co-regulated transcriptionally. 
 
Yamashita et al., 2007, had stated that Th2 development is dependent on 
the transcription factors STAT-6, GATA-3, and c - maf. Th1 and Th2 
development is mutually antagonistic and self-reinforcing, in part because 
IL-4 and IFN- antagonize one another at cellular and molecular levels. 
 
Th1/Th2 skewing in periodontitis: 
Balance of the two helper subsets determines what kind of adaptive immune 
response is utilised to eliminate infection. Periodontal tissue destruction is 
strongly associated with both Th1 and Th2 cytokine expression. Th1 
effectors produce inflammatory cytokines that can mediate tissue 
destruction, anti-inflammatory cytokines produced by Th2 cells are 
involved in tissue homeostasis during inflammatory destruction and 
subsequent repair or remodelling(Teng Y.T)
147
 CD4+ T cells participate in 




tissue inflammatory responses and alveolar bone destruction; through the 
cytokines they produce. (Teng Y.T)
148 
 Some studies reported that cytokine profiles of periodontitis patients were 
predominantly of Th1 type. But, other studies have stated that Th2 cytokine 
profile is expressed in periodontitis (Hourihaddad Y et al)
57 
Th1 cytokine profile is seen in early or stable lesion and Th2 cells are 
involved in advanced or progressive lesions. Production of IFN γ by Th1 
cells enhances phagocytic activity of both neutrophils and macrophages and 
hence containment of infection. However, lesion persists due to continual 
formation of plaque biofilm. If innate response is poor, low levels of IL12 
produced, poor Th1 response may occur, which may not contain the 
infection. 
Reinhardt RA et al (1988)
110
 evaluated lymphocyte subsets within gingival 
biopsies and in peripheral blood samples from the same patients using direct 
immunofluorescence. The T helper/T suppressor cell ratio did not vary 
significantly between blood and any gingival tissue disease group or 
location, but a trend toward lower relative numbers of Th cells in the 
sulcular infiltrates of active sites was noted.  
Wassenar A et al (1995)
160
 cloned and characterised T lymphocytes 
isolated from gingival tissue obtained from 4 periodontitis patients and 
tested their proliferative responses to  whole cell antigens of 




Porphyromonas gingivalis, Prevotella intermedia, Aggregatibacter 
Actinomycetemcomitans, human collagen type I, and bacterial Hsp and for 
the production of cytokines by flow cytometry analysis. He proposed that 
collagen specific CD4+ Th2 like T cells contribute to the chronicity of 
periodontitis but their modes of activation might be controlled by Th0 like T 
cells specific for periodontitis associated bacteria. 
Yamazaki K, Nakajima T, Hara K. (1995)
162
 showed that IL 4 is the 
prominent cytokine in periodontitis affected tissues. Immunoregulation of 
both periodontitis and gingivitis are T cell dependent, but in periodontitis 
Th2 cells predominate and thereby control B cell activation. 
According to Fujihashi et al (1996),
36
 when gingival mononuclear cells 
(GMC) were isolated from inflamed tissues of adult periodontitis examined 
by flow cytometry, 20-30% of lymphocytes were CD4+ T cells. Although 
human CD4+ T cells are capable of producing an array of Thl- and Th2-
type cytokines, the CD4+ T cells associated with periodontitis are limited to 
production of IFN γ, IL-6, IL-13 and IL-10.  
Gemmell E, Yamazaki K, Seymour GJ. (2002)
47
 showed that P. 
gingivalis-specific T-cells produced both Th1 and Th2 cytokines, regardless 
of the APC population. 
Gemmell E and Seymour GJ (2004)
45
 stated that mast cell stimulation and 
production of IL4 would encourage a Th2 type response, B cell activation 




and antibody production. If the antibodies are protective and clear infection, 
disease will not progress, but if they are non protective, lesion will persist 
and continued B cell activation would result in large amount of  IL1 and 
hence tissue destruction 
Ito H et al (2005)
61
 established T cell clones from the gingival tissues of 19 
periodontitis patients and examined their gene expression. All the gingival 
T-cell clones expressed mRNA for TGF-β1, CTLA-4, and CD25, and all the 
T-cell clones from peripheral blood expressed IFN-γ and TGF- β1 mRNAs. 
CD8+ cells: 
Naïve CD8+ cells express a number of cell surface receptors and ligands that 
enable them to home to secondary lymph nodes. The environment created in 
these lymph nodes allows rare antigen specific CD8+ cells to be activated.        
Differentiation involves expression and storage of large amount of enzymes. 
Modification of cell surface receptors occurs; allowing migration from lymph 
nodes to circulation and eventually into inflamed tissues, where they exert 
their effector function. Cytotoxicity is induced by perforin/granzyme pathway 
or Fas/FasL pathway. Tc1 cells secrete type I cytokines IL-2, TNF α and β, 
IFN γ. Tc2 cells secrete IL-4, 5,6,10  
In periodontal tissues, CTLs can be found next to the periodontal fibroblasts in 
deep gingival tissues, where direct cytopathic and degenerative changes occur. 
There is said to be a Tc2 like cytokine expression in periodontitis patients. 




These cells do not directly participate in periodontal tissue destruction; 
however they play some protective roles in fighting periopathogens by 
generating important cytokines for both innate and adaptive immune response 
and by cytolytic killing of bacterial infected or damaged tissue of cells.  
Celenligil H et al (1990)
19
 analysed the phenotypic properties of gingival 
lymphocytes in 12 adult periodontitis patients. CD4+ and CD8+ cells were 
evenly distributed within these infiltrates.   
 
Th1/Th2 reciprocity:  
The two Th1/Th2 subsets exert a suppressive effect on each other through a 
variety of mechanisms. Their signature cytokines, IL-4 and IFN-γ suppress 
each other, i.e., IFN suppress Th2 responses while IL-4 production down 
regulates Th1 responses. The intra cellular signals are also capable of 
similar responses. For example, GATA- 3 suppresses STAT- 4 and thereby 
Th1 responses, while STAT-5 reduces T-bet expression. T-bet by it, can 
down regulate GATA- 3 expression. 
 
 






 Th1 CELLS: 
Brandtzaeg P, Kraus FW, have stated that Th1 cells are believed to afford 
protection against the intracellular pathogens. These cells produce the 
interferons (IFN) that are involved in macrophage activation, which in turn 
plays an important role in phagocytosis, complement fixation and 
opsonisation. 
Development 
Th1 development requires inductive signals that initiate a network of 
intercommunicating intracellular events that culminates in the 
differentiation of the naive T cell to a differentiated Th1 cell.  




Inductive signals : 
Buduneli N, Bicakci N, Keskinogˇlu,  have reported that Th1 polarisation 
is induced by the cytokines IL-12 and IFN-α, both of which are present in 
the inflammatory milieu. These cytokines are normally produced by the 
dendritic cells or the natural killer (NK) cells. In the periodontal 
environment, dendritic cell infiltration has been strongly associated with 
gingival inflammation.  These cells have toll like receptors (TLR) on their 
surface that enable them to respond to the pathogen-associated molecular 
patterns (PAMPs)-lipopolysaccharide (LPS), fimbriae etc of the 
periodontopathogens. NK cells have also been identified in the inflamed 
periodontium and are thought to respond to a variety of stimuli, including 
lipid antigens such as lipotechoic acid, in a TLR independent, CD 1 
dependant manner.   
 Intracellular signalling pathway: 
IFN-α/ IFN-γ in conjunction with IL-12 activates signal transducer and 
activator of transcription (STAT) - 1 in the naive CD4 T cells. Activated 
STAT-1 upregulates the master regulator of Th1 differentiation – T box 
expressed in T cell (T- bet). Activation of T- bet leads to induction of the 
receptor IL-12Rβ2, making these cells more responsive to IL-12. This in 
turn, causes activation of STAT-4, which upregulates IFN-γ production by 
the Th1 cells. At the later stages of differentiation, IL-18Rα receptor 
expression is up regulated, thereby, making these cells responsive to IL-18. 




Concomitant action of IL- 12 and IL- 18 leads to the full repertoire of IFN-γ 
production that is characteristic of the effector function of Th1 cells. 
Gately et al., 1998,
40
 in experimental studies, had reported that IL-12, acting 
via the Stat4 signaling pathway, is the primary inducer of Th1 development. 
Mice deficient in IL-12, IL-12 receptor or Stat4 have markedly reduced Th1 
responses 
 
O’Garra, 1998,98 in experimental studies, had reported that while mice 
lacking IL-18 or IFN have defective in vivoTh1 responses, these cytokines do 
not directly induce Th1 differentiation but rather augment IL-12-induced Th1 
development. 
In contrast to Th2 differentiation, very little is known about the molecular 




 hypothesised that the only known transcription factors 




 documented that in the absence of either of these (STAT4 








Th2 CELLS:   
Th2 cells are thought to have evolved as protection against parasitic 
helminths. These cells produce IL-4 in addition to IL-5 and IL-13; cytokines 
that are involved in immunoglobulin (Ig) class switching in B cells. The 
importance of Ig-G that is produced as a result of this class switching in 
periodontal disease pathogenesis has been well documented.  
Development 
Inductive signals: 
Th2 development is induced by production of IL-4, which in turn is 
produced by the naive T cells or the mast cells/ macrophages. In the 
periodontal milieu, naive T cells constitute only a small proportion T cell 
infiltration within the tissues; it is comprised predominantly of the memory 
or the effector cells. 
 
Therefore, they are unlikely to be the major source of 
IL- 4 in the gingiva. On the other hand, both macrophages and mast cells 
have been identified in the periodontal environment and as early responders; 
they are the likely source of IL-4 production. 
Intracellular signalling: 
IL-4 signalling results in activation of STAT-6 which then up regulates the 
master switch of Th2 differentiation, GATA-binding protein-3 (GATA- 3).  
In addition to GATA-3, STAT- 5 signalling is also required for complete 
Th2 differentiation. GATA-3 auto-amplifies its own gene, subsequent 




activation is, therefore, not dependant on other signals. Consequently, Th2 
cells are thought to be a more stable phenotype.   
 Nelms et al., 1999,
96 
in experimental studies has shown that the critical Th2-
inducing cytokine is IL-4, which mediates its effects on naive Thp cells 
through the Stat6 signaling pathway. Mice lacking either IL-4, IL-4 receptors, 
or Stat6 fail to develop Th2 cells. 
 
Seder and Paul, 1994,
125
 has reported that Th1 and Th2 cytokines both 
promotes the growth/differentiation of their subset and inhibit the 
growth/differentiation of the opposing subset. For example, IL-4 produced by 
Th2 cells acts in a positive manner to activate IL-4 receptors present on naive 
Thp cells to initiate the Th2 differentiation process. 
 
Hodge et al 1996,
56
 stated that the Th2 specific transcription factor, c-maf, 
along with NFAT & NFAT interacting protein confers on a non-Tell the 
ability to produce IL-4. 
 
Kim et al 1999,
75
 stated that mice with c-maf deficient have impaired IL-4 
production. 
 
Zhang et al 1997,
171
 hypothesized that GATA-3 like c-maf is Th-2 specific 
and upregulates during Th-2 differentiation. 




Zhung, Flavell et al 1997, Ouyang et al 1998,
171,103
 stated that GATA-3 
appears to regulate a broad spectrum of Th-2 cytokine genes. 
 
Agarwal and Rao et al 1998,
3
 hypothesized that along with GATA-3, STAT-
6 is also necessary for chromatin remodelling of IL-4/IL-13 locus found to 
occur in developing Th-2 cell. Thus GATA-3 and STAT-6 have more global 
influence on Th-2 cytokine gene expression and mediates this effect by 
directly altering the chromatin structure of Th-2 specific gene loci. 
 
 
Th1 and Th2 differentiation: 
 
 
In 1989, Mosmann and Coffman,
94
 reported that CD4+ T helper cells 
could be divided based on their cytokine profile. The Th1 cells produce IL-
2, IFN-γ and their development is regulated by the transcription factors T-
bet and STAT-4. Th2 cells are regulated by STAT-6, c-maf and GATA-3 
and they produce cytokines such as IL-4, IL-5, IL-9 and IL-13. Hyper 
activation of Th1 and Th2 type responses results in over production of 
cytokines leading to auto-immune disorders and allergic diseases 
respectively. The presence of T-regulatory cells in both scenarios prevents 
diseases manifestations by suppressing their activity.  





                              Fig: Th differentiation 
Th1 cells produce IL-2 which induces strong proliferation of T cells, they 
promote B cells to produce IgG2a isotype antibody.Th1 mediates activation 
of macrophages through IFN γ. Th1 secreted IFN γ is mainly responsible for 
pro inflammatory effects of macrophages and cytotoxic T cells. IL12, IFN γ 
induce Th1 development.
 
Th2 After activation in secondary lymph nodes Th2 cells are retained in T 
cell areas of B cell germinal centres, where they exert their helping effects 
by direct contact with antigen presenting B cells and production of 
cytokines. IL 4, 13 induces B cell class switching. IL 5 activates 
eosinophils. IL6, IL10 inhibit generation of Th1 cells, reinforcing bias to 
Th2 response. Th2 cells stimulate high titres of antibody production. IL4, 6 
required for Th2 development 





Fig : Th1 and Th2 cells 
 
Th1 differentiation:  
T-bet:  
Szabo et al., 2000,
141
 have stated that T-bet, also known as Tbx21 belongs 
to the T-box family of transcription factors and is the only known T-box 
gene specifically expressed in the lymphoid system. T-bet is rapidly and 
specifically induced in developing Th1 but not Th2 cells, Lighvani et al., 
2001,
80
 have stated that T-bet expression appears to be controlled by both 
TCR and IFN-R-STAT1 signals, Lighvani et al., 2001; Mullen et al., 




2001; Afkarian et al., 2002,
80,2
 have reported that not by the IL-12-STAT4 
pathway.  
Mullen et al., 2002,
95
 have stated that T-bet expression seems to be self 
regulated; retrovirally expressed T-bet induced T-bet in Th2 cells, Afkarian 
et al., 2002,
2
 have stated that it is dependent on STAT1, likely through IFN-
 signaling. Indeed, IFN-R-STAT1 signaling maintains high-level of T-bet 
expression in developing Th1 cells. Afkarian et al., 2002,2 have stated that 
IFN- promotes Th1 commitment through T-bet.  
Szabo et al., 2000,
141
 in vitro studies have shown that retrovirus-mediated 
over-expression of T-bet in differentiating or fully differentiated Th2 cells 
resulted in an induction of IFN expression, accompanied by a reduction of 
IL-5 and, to a lesser extent, of IL-4. Such an effect of T-bet is cell-intrinsic 
because IL-4 and IL-5 expression were unchanged in control Th2 cells that 
co-existed in the same culture.  
Afkarian et al., 2002,
2
 in experimental studies have shown that the strength 
of TCR signaling appeared to be important in quantitatively affecting T-bet 
expression levels and thus Th1 differentiation. In addition, T-bet-deficient 
CD4 T cells failed to produce IFN- in response to TCR stimulation, even 
under Th1-polarizing conditions. Therefore, T-bet is critically involved in 
initiating Th1 development through both inducing the Th1 program and 
repressing the opposing Th2 program. 





Hlx is a Th1-specific homeobox gene that interacts specifically with T-bet. 
Mullen et al., 2002,
95
 have shown that its expression becomes detectable 3 
days after Th1 differentiation and is restricted to Th1 but not Th2 T cell 
clones. Hlx appears to be a target gene for T-bet because retrovirus-mediated 
expression of T-bet and a dominant negative form of T-bet induced and 
inhibited Hlx expression, respectively. Mullen et al., 2002,
95
 have stated that 
Hlx and T-bet synergistically promote IFN-g expression when co-expressed. 
Thus, as a cofactor for T-bet, Hlx appears to enhance the activities of T-bet 
and thus Th1 differentiation. Further study is needed to investigate whether 
Hlx promotes or is required for optimal Th1 responses under physiological 
conditions. 
 
STAT4:   
Ouyang et al., 1999; Yang et al., 1999,
102,164
 have stated that STAT4 is 
critical for IL-12 signaling and also for differentiation of Th1 cells. The 
mechanism of STAT4-promoted IFN- expression is largely unknown. 
 
Xu et al., 1996 have stated that STAT4 may act through binding to regulatory 
genomic regions of the IFN- gene or through interacting with general 
transcriptional co-activators p300/CBP (Bhattacharya et al., 1996; Zhang et 




al., 1996; Korzus et al., 1998).
17,77
 Thus STAT4 is critical for amplifying 




GATA-3 is a member of the GATA family of transcription factors. While it 
was previously shown to be critical for embryo development, Zheng and 
Flavell, 1997,
174
 have shown that GATA-3 dictates Th2 differentiation by 
regulating Th2 cytokine production through binding to the IL-4 locus that 
encompasses the IL-4, IL-5 and IL-13 genes. Forced expression of GATA-3 in 
Th1 cells led to the induction of IL-4 production (Zheng and Flavell, 
1997).
174
 Th2 differentiation and responses are abolished in vitro and in vivo 
when GATA-3 is deficient in T cells. Zhu et al., 2004,
178
 have shown that 
even in fully differentiated Th2 cells, when GATA-3 is blocked then IL-5 and 
IL-13 production will be affected but not IL-4 production ,due to the fact that 




In vitro studies by Shimoda et al.,1996; Takeda et al., 1996,
131,142
 have 
shown  that STAT6, activated by IL-4 stimulation, is the major signal 
transducer in IL-4-mediated Th2 differentiation. However, in vivo studies by 




Finkelman et al., 2000; Jankovic et al., 2000; Min et al., 2004,
33,65,88
  have 
shown that Th2 responses can be obtained independently of STAT6. 
 
Kurata et al., 1999; Zhu et al., 2001,
78,176
 in vitro studies have shown that 
one of the mechanisms of STAT6 is to promote Th2 differentiation through 
inducing high levels of the transcription factorGATA-3. STAT6 activities 
were found necessary and sufficient for inducing GATA-3. 
 
c-Maf, IRF-4: 
c-Maf is an AP-1 family transcription factor selectively up-regulated in Th2 
cells. Kim et al., 1999,
75
 have stated that c-Maf is required for the production 
of IL-4 but not other Th2 cytokines.  
 
Lohoff et al., 2002; Rengarajan et al., 2002,
82,111
 have stated that IRF-4 is 
also shown to be required for Th2 cell differentiation. IRF-4-deficient cells 
produce much less IL-4, but this defect can be rescued by over-expression of 
GATA-3, suggesting that IRF-4 promotes Th2 differentiation through up-
regulating GATA-3. 
 
In vivo studies by Nicolas Dutzan, Jorge Gamonal et al,
181
 have shown that, 
in active periodontal lesions, T bet has been increased to about 2.8fold when 




compared to GATA-3. Whereas IFN- was the highest over expressed 
cytokine that was detected in active periodontal lesion.   
 
In vivo studies by Ohyama et al in 2009,
101,
 have stated that IFN did not 
vary significantly after treatment. They also discovered that there was no 
significant difference in expression levels of IFN between periodontal lesions 
and control sites. 
 
Lester et al 2007,
80
 have shown that the gingival concentration of IFN was 
significantly greater at moderate CAL sites than at normal-slight CAL sites, 
and less than normal level in severe CAL sites. In active periodontal lesions, 
IFN  and T-bet was significantly over expressed compared with inactive 
lesions. They came to conclusion that IFN might play a destructive role in the 
pathogenesis of periodontal disease.  
 
De Heens et al,2009,
24
 have stated that  the level of IL-4 increased 
significantly after non surgical periodontal treatment. Some studies suggested 
that IL-4 and Th-2 biased response are protective against periodontitis 
progression. The high levels of alveolar bone loss in mice induced by 
Porphyromonas gingivalis were inversely correlated with the Th-2 response to 
this bacterium, but others suggest the opposite. An elevated Th-2 profile in 
smokers of periodontitis patients may constitute a risk for conversion of 




periodontal stability into progressive disease. Based on this study they 
consider Th-2 cells and Th-2 related cytokines might play a protective role in 








Materials and methods: 
Recruitment of samples into the study:  
Age and gender matched subjects were recruited from the outpatient 
department of Ragas Dental College and Hospital, Chennai. A written consent 
by the patient to participate in the study will be obtained. The study has been 
approved by our Institutional Review Board. The age of subjects in both the 
healthy and diseased groups was ranging from 35 to 55 years. 
Selection criteria: 
Group A: healthy subjects (control group) who had PD <3mm with no 
clinical attachment loss and BOP <10% 
Group B: Advanced chronic periodontitis patient (Test group) who had PD 
   mm, clinical attachment loss  5mm and bleeding on probing, atleast one 
or more teeth indicated for extraction. 
Healthy tissue samples were obtained from patients who had reported to the 
department for crown lengthening or during impacted/IIIrd molar removal 
Diseased tissue samples from patients indicated for extraction in 
advanced/severe periodontitis. 
The dimension of the tissue sample: 3mm   2mm. 
 





 Patients with history of periodontal therapy or antibiotic therapy in the past 6 
months  
 Patients with history of systemic diseases that may affect the periodontal 
status 
 Pregnancy and Lactation 
 Smokers 
 
Homogenization of tissue samples: 
Tissue samples were completely minced and homogenized in a homogenizer 
using TRY reagent. 
The obtained tissue samples were thoroughly washed with PBS (Phosphate 
buffered saline) and stored in RNA later (RNAase free solution) and stored in 
-80°C until further RNA extraction is carried out.  
Total RNA extraction: 
Isolation of total RNA: 
 Total RNA was isolated from health and diseased tissue by using total 
RNA isolation reagent (Trisol, Medox) kit. 
 





 Single step guanidium acid phenol method emphasizes on the ability of 
guanidium isothiocyanate (GITC) to lyse cells, denature protein and inactivate 
intracellular ribonuclease rapidly.  The presence of -mercaptoethanol in the 
mixture enhances the solubilization properties of the GITC extraction buffer.  
Acid phenol extraction (pH<5.0) selectively retains cellular DNA in the 
organic phase and aids in the extraction of proteins and lipids.  The addition of 
chloroform further removes lipids and establishes two distinct phases, an 
organic phase containing the DNA, proteins and lipids and an aqueous phase 
containing the RNA. 
Reagents: 
1. Trisol kit has the following components: Phenol, guanidium isothiocyanate, 
urea, detergents, buffering agents and stabilizers. 
2. Chloroform (Molecular biology grade). 
3. Isopropanol (Molecular biology grade). 
4.75% ethanol (Analytical grade) – to 7.5 ml of absolute ethanol 2.5 ml of 
autoclaved deionised water was added. 
Procedure: 
 1ml Trisol was added to control and treated cells and swirled gently for 
15 min and then kept at 4C for 5 min to permit complete dissociation of 




nucleoprotein complexes.  To this 0.2 ml chloroform was added, shaken 
vigorously for 15 sec and placed at 4C for 5 min.  The lysate was then 
centrifuged at 12,000 rpm for 15 min at 4C, which yielded, lower organic 
phase containing DNA and proteins and upper aqueous phase containing 
RNA.  The volume of the aqueous phase was about 40-50% of the total 
volume of the lysate. 
 The aqueous phase was carefully transferred to a fresh eppendorf 
micro centrifuge tube without disturbing the interphase.  Equal volume of 
isopropanol was added, mixed and kept at 4C for 10 min.  It was again 
centrifuged at 12,000 rpm for 15 min at 4C to precipitate the RNA. 
 The supernatant was removed and the pellet was washed with 75% 
ethanol and air-dried.  The RNA pellet was then dissolved in 30l of sterile 
deionised water and placed in water bath at 60C for 10 min to ensure 
maximum solubility of RNA.  The RNA sample was subsequently vortexed 
gently and quantified before storing at – 80C. 
Quantification of RNA: 
 Diluted RNA sample was quantified spectrophotometrically by 
measuring the absorbance (A) at 260 nm.  An absorbance of 1 is equivalent to 
RNA concentration of 40g/ml.  Therefore, the yield can be calculated by 
multiplying the absorbance at 260 nm with dilution factor of 40.  The purity of 




the RNA was assessed by determining the absorbance of the sample at 260 nm 
and 280 nm.  The purity of RNA obtained was around 1.8. 
Quantitative Real Time-PCR Analysis of T–bet & GATA-3 Expression: 
Principle 
Real time-PCR selectively amplifies the first strand of cDNA that has been 
synthesized in vitro by RNA polymerase from mRNA templates by reverse 
transcription. The cDNA is first denatured by heating in the presence of a 
large molar of two oligonucleotide primers and the four dNTPs. The 
reaction mixture is then cooled to a temperature that allows the 
oligonucleotide primers to anneal to their target sequences, after which the 
annealed primers are extended with DNA polymerases. The cycle of 
denaturation, annealing and DNA synthesis is then repeated many times. 
Real-time experiments monitor and report the accumulation of PCR 
product, as detected by increased fluorescence, during thermal cycling. Data 
collection during the early exponential phase of PCR allows the software to 
accurately calculate initial template quantities. 
First strands cDNA synthesis:  
Kit Components: 
 Omniscript reverse transcriptase (RT - enzyme)   
 RNAase inhibitor  (10 U/ l) 
 Oligo -  dT primer (10  l) 




 dNTP - Mix  (5 mM each dNTP) 
 10 Buffer RT 
 RNase - free water 
 
Quantitative Real time PCR - SYBR
® 
Green I Assay kit 
(Qiagen,Germany) 
Kit Components  
 2X Reaction buffer (7.5ml):  qPCR Master Mix Plus for SYBR® Green I 
dNTP containing dNTPs, Hot Goldstar DNA polymerase, MgCl2 (5mM 
final concentration), SYBR
®
 Green I, stabilizers and passive reference. 
 50 mM MgCl2 (1.5 ml). 
 The resulting cDNAs from RT reaction were diluted with Milli-Q water 
(1:10). Real Time-PCR was carried out on Mx 3000p Multiplex 
quantitative PCR system (Stratagene). Reaction was performed using 5.0 
µl of 2X reaction buffer,  1µl of 100 nM of both forward and reverse 
primers of gene of interest, 1 µl of forward and reverse primers of 18S 
rRNA, 3.0 µl of diluted cDNA  was made up to a 10µl reaction. The 
thermal cycling protocol was as follows: 95
o
C for 5 minutes, followed by 
40 cycles of PCR at 95
o
C for 30 seconds and 58
o
C for 30 seconds. All 
reactions were performed in triplicate along with no template control 
(NTC). Melt curve analysis was performed using the thermal cycling 
programmed at 50ºC - 95ºC for each sample to determine the presence of 




multiple amplicons, nonspecific products, and contaminants.. The relative 
amount of mRNA was calculated by using the comparative Ct method.  
 
 All the reactions described above were carried out in triplicate. 
     T-bet : 
T-bet forward: TCC AAG TTT AAT CAG CAC CAG A 
T-bet reverse: TGA CAG GAA TGG GAA CAT CC 
 
     GATA-3: 
GATA forward: ATC ATT AAG CCC AAG CGA AG 
GATA reverse: TCT GAC AGT TCG CAC AGG AC 
 
Once the amplification was generated at the end of the reaction, the 













The values obtained in the Real time-RT PCR was interpreted using the 
formula of fold change, 2
-∆∆ct = [ct of gene of interest – ct of internal control] 
of disease sample – [ct of gene of interest – ct of internal control] of health 
sample.
180 
This form of equation may be used to compare the gene expression in two 
different samples (health and disease) or (treated and untreated). Each sample 









Gingival tissue samples were obtained from 10 patients each from 
periodontally healthy and diseased groups and total RNA isolated and 
extracted. The mRNA expression for T-bet and GATA-3 was evaluated by 
using Real time RT-PCR.  
The present study results showed the expressions of T-bet and GATA-3 are 
summerarized in the following table 1. 
 
T-bet: 
The results reveals that the mean ct value of the health group is 30.94 0.03 
and for the diseased group is 25.45 0.02. The Delta CT value derived from 
 
T-bet 













Disease 25.45 0.02 14.22 0.00 11.23 0.02 1.12 0.02 











Disease 28.79 0.09 14.22 0.00 14.58 0.09 -4.39 0.09 
Health 28.76 0.06 18.59 0.00 10.18 0.06 0.00 0.05 




the formula, [ 2
-∆∆ct  = (ct of gene of interest – ct of internal control) of disease 
sample – (ct of gene of interest – ct of internal control) of health sample] is 
12.35 0.03 for health group and 11.23 0.02 for diseased group. This shows 
that the amplification has occurred in fewer cycles in disease than in health. 
This is represented as fold change from health to disease. An increase of 
1.12 0.02 fold change was observed in disease when compared to health.   
                      Mean+SD - internal control =  Delta ct  
2
-∆∆ct  =       25.45        -    14.22              =  11.23    (disease sample) 
                        30.94        -    18.59              =   12.35    (health sample) 
Fold change = 11.23 - 12.35 = 1.12  
 
GATA-3: 
Similarly in GATA-3 results reveals that the mean ct value of health group is 
28.76 0.06 and diseased groups 28.79 0.03. The Delta CT values derived 
from the formula, [ 2
-∆∆ct 
 = (ct of gene of interest – ct of internal control) of 
disease sample – (ct of gene of interest – ct of internal control) of health 
sample]  is 10.18 0.06 for healthy group and 14.58 0.09 for diseased group. 
This shows that the amplification has occurred later than that of health, with 
decreased expression in disease group than in health group. This is represented 




as fold change from health to disease. A decrease of 4.39 fold was observed in 
disease group when compared to health.  
                      Mean+SD - internal control =  Delta ct  
2
-∆∆ct  =       28.79        -    14.22              =  14.58    ( disease sample ) 
                        28.76        -    18.59              =   10.18    ( health sample ) 
Fold change = 14.58  - 10.18 = 4.39  
 
 





It is well established that the onset/ progression of periodontal disease is 
largely determined by the nature of the inflammatory response to the 
challenge put forth by the plaque/biofilm.
149
 The central role played by the 
T cells in the pathogenesis of periodontal disease, was established in early  
1940.
106
                               . 
However, with a greater understanding of their biological functions, T 
cells are now believed to be involved in the homeostasis of periodontal 
tissues,
41
 modulation of the inflammatory/immune responses
12
 and 
mediation of the bone loss observed in periodontal disease.
150
  
T cells are classified based on their function into various categories such as 
helper T (Th) cells, cytotoxic T (Tc) cells and regulatory T (Treg) cells. The 
presence of two different subsets of Th cells-Th1 and Th2 was described by 
Parish and Liew.
106
 Later, Mossman and Coffman delineated two distinct 
cytokine profiles associated with the Th1 and Th2 cells.
92
 
While the CD8+ cells may be involved in killing and removing bacteria 
infected damaged host cells, they do not directly mediate tissue 
destruction. The CD4+ T cells are directly involved in the inflammatory 
response observed in periodontal disease, through mediation of both hard 




In periodontal disease, cytokines are central to the pathogenic process 
involved in disease activity. It has been postulated that "appropriate" 




cytokine production results in protective immunity, while "inappropriate" 
cytokine production leads to tissue destruction and disease progression.
42
  
It has been established that the cytokines expressed by these cells 
contribute to the state of protective verses destructive phases of disease 
progression. Based on their cytokine expression profiles, the CD4+ T 
helper cells have been classified into 2 distinct subsets namely, Th1 
&Th2.
94
 Th1 cells differentially produce IL-2& IFN-, while Th 2 cells 
produce IL-4, IL-5& IL-6. The two subsets exert a suppressive effect on 
each other, through a variety of mechanisms. 
Earlier studies have postulated a role for Th1 &Th2 subsets in periodontal 
disease.
45
 The pathogenesis of periodontitis was classically reviewed in 
terms of Th1/Th2 paradigm where the Th1 cytokines were associated with 
early stage of lesions, while the destructive Th2 cytokines in the advanced 
lesion.
126 
Irrespective of the predominant Th subset present in progressive lesions, the 
cytokine milieu is thought to be important for both differentiation and 
functioning of the Th profile.
15 
Two sets of cytokines are intimately associated with the Th subsets-
inducers and effectors. The inducing cytokines are responsible for 
establishing the lineage largely to the activation of the transcription 
factors. It is known that master transcription factor T-bet along with 




STAT1 drives towards Th1 differentiation,
138,69
 while GATA3, STAT 6 & 
C-maf drive towards Th 2 differentiation .
178,142 
The transcriptional regulation of the Th cell differentiation in periodontal 
disease still remains an area of concern. With the emerging concepts on 
the plasticity of the Th cells the role of the transcription factors have 
gained more relevance today, than never before.
8 
Hence the aim of this 
study was to evaluate the transcriptional regulation of Th1 &Th2 subsets 
in periodontal health and disease. 
Gingival tissue samples obtained from periodontally healthy individuals 
and from patients with advanced periodontal disease have been included in 
the study. Healthy tissue samples were obtained from patients who 
reported for crown lengthening or for third molar extraction. The diseased 
tissue samples were from sites of advanced periodontal disease, as 
indicated by probing depth > 8mm, attachment loss > 5mm and 
radiographic evidence of greater than 2/3rds of bone loss, and hence 
indicated for extraction. 
The tissue samples were carried in an RNAase inhibitor containing 
solution and homogenized immediately. Cryopreservation was not done to 
prevent any degradation of proteins. Total RNA was obtained from the 
homogenates using total RNA extraction kit. Real time – Reverse 
transcription PCR was then carried out with SYBR green containing 




master mix kit to evaluate the mRNA expression of T-bet and GATA-3 in 
periodontal health and disease.   
The results of our study showed a marginal, insignificant increase in the 
levels of T-bet in periodontal disease when compared to health, while that 
of GATA-3 had shown a significant decrease in periodontal disease, when 
compared to health. 
It would appear that these results suggest a minor insignificant increase of 
the Th1 cell and more profound down regulation of Th2 in advanced 
periodontal lesions. These results seem to suggest that advanced lesions 
are more likely to be Th1, rather than Th2 dominated. 
Th1 dominated lesions are thought to be associated with increased 
production of IFN-, which is its signature effector cytokine. IFN- is 
closely associated with macrophage activation.contineous production of 
IFN- May therefore lead to excessive presence of macrophage in chronic 
inflamed periodontal tissues. This could, in turn, leads to excessive 
osteoclastic activity, causing the bone loss that is a classical feature of 
progressive periodontal disease. 
At the same time, a reduced Th2 activity could lead to the suppression of IL-
4 and IL-10 production.IL-4 is known to be anti inflammatory cytokine that 
exerts significant effect on dampening of the inflammatory response. Further 
IL-10 is known to exert strong suppressive effect on osteoclastogenesis. 
25
 




The decrease in the level of these two important cytokines could, have led 
to the uncontrolled inflammatory response and bone loss observed in 
advanced periodontitis lesions. 
The results of our study are in agreement with that of Fujihashi K, 
Yamamoto M,
35,36
 et al who have suggested similar roles for the Th1/Th2 
cells in periodontitis. Previous literature also suggests that Th1and Th2 
subsets have a counter balancing and regulatory effects on each other. 
These effects are exerted at both transcriptional and effector cytokine 
levels. 
Recent evidence indicates that T-bet and GATA-3 have direct suppressive 
effects on each other. The primary effect in the lesion observed could 
therefore have been due to upregulation of T-bet. This upregulation could 
in itself have led the suppression of GATA-3. It could be hypothesized 
that although T-bet upregulation did not show much stastical significance, 
its influence on the progression of periodontal disease was profound. 
These results must however be interpreted with caution. Transcription 
factors exert their influence on differentiating cells through binding on the 
promoter region of the DNA. However, the production of these 
transcription factors is influenced more by the inducing signals in the 
inflammatory milieu, than the state of differentiation of the Th cells. 
Consequently, T-bet production is directly related to the presence of IFN-
α, IL-12, while GATA-3 is dependent on the IL-4 levels. 




As the lesions in our study where end stage of periodontal disease, with 
active inflammation, the levels of the anti inflammatory IL-4 levels were 
likely to be decreased. Previous studies have shown decreased IL-4 levels 
in both mRNA in tissues and proteins in the inflammatory fluids (GCF and 
saliva) in progressive periodontal lesions. This decreased Il-4 production 
could have directly influenced in lowered GATA-3 expression observed in 
our samples. 
The effect of these transcription factors are however not so straight 
forward. Both T-bet and GATA-3 are known to be the Master 
transcription factors that act on differentiating Th1 and Th2 cells 
respectively. Therefore T-bet acts primarily through binding to the 
promoter region of the IFN gene locus, while GATA acts through binding 
to the IL-4 gene locus.  If the transcription factors were utilized by the 
differentiated cells, their tissue levels could presumably be depleted. 
It could thus be argued that a decrease in the transcription factor levels 
may well be because of a greater establishment of a terminally 
differentiated Th cell lineage. In other words, a decrease in GATA could 
be because all the available GATA present were used up by the 
differentiated Th2 cells. This means that the tissue may, in fact be 
characterized by a preponderance of Th cells. 
Seymour and co-workers,
127
 have suggested that the early stable periodontal 
lesion was associated with a robust infiltration of Th1 cells. On the contrary, 






 have proposed that a Th2 cytokine profile was associated 
with a stable lesion, while the progressive lesion was characterized by the 
Th1 profile. 
A clearer picture could have emerged, had the effector cytokines been 
assessed simultaneously. In the absence of these cytokine profiles, it is 
difficult to interpret the results conclusively. 
However, it is clear that an imbalance in the transcriptional activation of 
the Th1/Th2 cells is closely associated with chronic periodontitis lesions. 
A similar imbalance in the effector cytokine profile is known to influence 
disease activity. 
A complete picture requires a concomitant study of the inducing, intra 
cellular and effector signals involved in Th functions. 
The evaluation of the transcription factors should have been done in 
different stages of the disease process, viz in progression of gingivitis to 
periodontitis, early stages of periodontitis and in chronic lesions. This is 
one of the limitations of our study. 
Similarly it would have been more appropriate to have evaluated the 
cytokine expressed by these two subsets to draw more meaningful 
conclusions. Also the simultaneous study of the newer subsets viz. the 
Th17, T reg and other Th subsets should be taken as the Th1/Th2 
paradigm alone is insufficient in solving the many dilemmas that still 




continue to linger in the pathogenic mechanisms that trigger the 
periodontal disease process. 
 
 




  Summary and conclusion: 
The aim of the present study is to evaluate the transcriptional regulation of 
Th1 and Th2 subsets (T- bet and GATA-3), in Periodontal Health and 
Disease. 20 patients who attended the outpatient department of Ragas Dental 
College and Hospitals, Chennai were enrolled in the study.   Patients were 
divided into two groups based on their periodontal health status- 10 Healthy 
and 10 Periodontitis patients. The gingival tissue biopsy samples were 
processed for real time reverse transcription polymerase chain reaction to 
detect the mRNA expression of T-bet and GATA-3 in periodontal health and 
disease samples.  
The mRNA expression of the master transcription factor of Th1 subset, T- 
bet showed a marginal increase of about 1.31 fold. While the GATA-3 
levels showed a 4.39 fold decrease from disease to health. It would appear 
that these results suggest an insignificant increase of the Th1 cell and more 
profound down regulation of Th2 in advanced periodontal lesions. These 
results indicate that advanced periodontal lesions are more likely to be 
dominated by Th1, rather than Th2 subsets. 
Understanding the mechanism of transcriptional regulation of Th subsets 
in the pathogenesis of periodontal disease would result in the development 
of new therapeutic agents, aiming at these transcriptional factors which 
might be beneficial in suppressing the periodontal disease in future. 




However further investigations are required to add credibility to this result 
of the present study.  
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 Table representing the fold change of mRNA expression of T-bet and GATA-














Disease 25.45 0.02 14.22 0.00 11.23 0.02 1.12 0.02 
Health 30.94 0.03 18.59 0.00 12.35 0.03 0.00 0.03 
 
GATA-3 






Disease 28.79 0.09 14.22 0.00 14.58 0.09 4.39 0.09 
Health 28.76 0.06 18.59 0.00 10.18 0.06 0.00 0.05 
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Amplification plots and Dissociation curve of T-bet and GATA-3.  
 
        
